- Home
- HQI vs SLDB Comparison
HQI vs SLDB Comparison
Compare HQI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQI
- SLDB
- Stock Information
- Founded
- HQI 2002
- SLDB 2013
- Country
- HQI United States
- SLDB United States
- Employees
- HQI N/A
- SLDB N/A
- Industry
- HQI Professional Services
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HQI Consumer Discretionary
- SLDB Health Care
- Exchange
- HQI Nasdaq
- SLDB Nasdaq
- Market Cap
- HQI 196.4M
- SLDB 212.2M
- IPO Year
- HQI N/A
- SLDB 2018
- Fundamental
- Price
- HQI $14.43
- SLDB $4.85
- Analyst Decision
- HQI Strong Buy
- SLDB Strong Buy
- Analyst Count
- HQI 2
- SLDB 10
- Target Price
- HQI $18.00
- SLDB $17.50
- AVG Volume (30 Days)
- HQI 11.7K
- SLDB 295.0K
- Earning Date
- HQI 11-07-2024
- SLDB 11-06-2024
- Dividend Yield
- HQI 1.68%
- SLDB N/A
- EPS Growth
- HQI N/A
- SLDB N/A
- EPS
- HQI 0.10
- SLDB N/A
- Revenue
- HQI $36,279,000.00
- SLDB N/A
- Revenue This Year
- HQI N/A
- SLDB N/A
- Revenue Next Year
- HQI $8.01
- SLDB N/A
- P/E Ratio
- HQI $101.70
- SLDB N/A
- Revenue Growth
- HQI 0.28
- SLDB N/A
- 52 Week Low
- HQI $11.39
- SLDB $2.21
- 52 Week High
- HQI $17.31
- SLDB $15.05
- Technical
- Relative Strength Index (RSI)
- HQI 55.60
- SLDB 32.62
- Support Level
- HQI $14.25
- SLDB $5.39
- Resistance Level
- HQI $14.76
- SLDB $6.19
- Average True Range (ATR)
- HQI 0.57
- SLDB 0.39
- MACD
- HQI 0.08
- SLDB -0.02
- Stochastic Oscillator
- HQI 84.04
- SLDB 2.00
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The primary source of revenue for the company is royalty fees based on the operation of its franchised offices.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.